Citations

Showing 10 of 108094 citations.

Articular Contact Area and Pressure in Posteromedial Rotatory Instability of the Elbow
Bellato, Enrico , Kim, Young Bok , Bachman, Daniel R. , Berglund, Lawrence J., Hooke, Alexander W. , O’Driscoll, Shawn W. , Fitzsimmons, James S. , Kim, Youngbok, O'Driscoll, Shawn W., Fitzsimmons, James S

Mayo Clinic

Journal of Bone and Joint Surgery | March 21, 2018 | Volume: 100 | Issue: 6 | Pages: e34

10.2106/jbjs.16.01321 | PMID 29557868 Get It

Background: Joint incongruity in posteromedial rotatory instability (PMRI) has been theorized to determine early articular degenerative changes. Our hypothesis was that the articular contact area and contact pressure differ significantly between an intact elbow and an elbow affected by PMRI. Methods: Seven cadaveric elbows were tested under gravity varus stress using a custom-made machine designed to simulate muscle loads and allow passive elbow flexion (0° to 90°). The mean contact area and contact pressure data were collected and processed using the Tekscan sensor and software. After testing the intact specimen (intact elbow), a PMRI injury was simulated (PMRI elbow) and the specimen was tested again. Results: The PMRI elbows were characterized by initial joint subluxation and significantly elevated articular contact pressure. Both worsened, corresponding with a reduction in contact area, as the elbow was flexed from 0° until the joint subluxation and incongruity spontaneously reduced (at a mean [and standard error] of 60° ± 5° of flexion), at which point the mean contact pressure decreased from 870 ± 50 kPa (pre-reduction) to 440 ± 40 kPa (post-reduction) (p < 0.001) and the mean contact area increased from 80 ± 8 mm 2 to 150 ± 58 mm 2 (p < 0.001). This reduction of the subluxation was also followed by a shift of the contact area from the coronoid fracture edge toward the lower portion of the coronoid. At the flexion angle at which the PMRI elbows reduced, both the contact area and the contact pressure of the intact elbows differed significantly from those of the PMRI elbows, both before and after the elbow reduction (p < 0.001). Conclusions: The reduction in contact area and increased contact pressures due to joint subluxation and incongruity could explain the progressive arthritis seen in some elbows affected by PMRI. Clinical Relevance: This biomechanical study suggests that the early degenerative changes associated with PMRI reported in the literature could be subsequent to joint incongruity and an increase in contact pressure between the coronoid fracture surface and the trochlea.
Identification of compound heterozygous variants in OPTN in an ALS-FTD patient from the CReATe consortium: a case report
Pottier, Cyril , Rampersaud, Evadnie , Baker, Matt , Wu, Gang , Wuu, Joanne , McCauley, Jacob L. , Schüle, Rebecca , Bermudez, Christin, Cooley, Anne , Wallace, Marielle, Zhang, Jinghui , Benatar, Michael , Rademakers, Rosa , Pottier, Cyril , Wuu, Joanne , Züchner, Stephan , Hussain, Sumaira , Taylor, J. Paul , Wu, Gang , McCauley, Jacob L

Mayo Clinic

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration | March 21, 2018 | Volume: 19 | Issue: 5-6 | Pages: 469-471

10.1080/21678421.2018.1452947 | PMID 29558868 Get It

Comparison of outcomes between axial radial and axial ulnar carpal injuries
Boe, Chelsea C., Shannon, Steven F. , Shin, Alexander Y.

Mayo Clinic

Journal of Hand Surgery (European Volume) | March 21, 2018 | Volume: 43 | Issue: 7 | Pages: 712-717

10.1177/1753193418764276 | PMID 29558849 Get It

Axial carpal injuries are rare entities where a traumatic force transmits through the intermetacarpal space, dissociating the carpometacarpal joint and disrupting the distal carpal row in an axial radial or axial ulnar pattern via true axial force or compressive crush mechanism. Differences in outcomes remain unclear with regard to the specific type of axial carpal injury pattern. A retrospective case series identified 37 wrists (in 37 patients) over 25 years who presented to a Level 1 trauma centre, with 20 wrists experiencing an axial radial injury and 17 wrists experiencing an axial ulnar injury. Of all the variables evaluated, only axial radial injuries were identified as predictors of poor outcome as defined by Mayo Wrist scores with univariate analysis demonstrating 6 times increased risk and multivariate analysis demonstrating 15 times increased risk of a poor outcome compared with axial ulnar injuries. This knowledge will provide prognostic information to surgeons managing patients with these severe injuries. Level of evidence: IV
Determining the Validity and Accuracy of Multiple Activity-Tracking Devices in Controlled and Free-Walking Conditions
Gaz, Daniel V., Rieck, Thomas , Peterson, Nolan W., Ferguson, Jennifer A., Schroeder, Darrell R. , Dunfee, Heather A., Henderzahs-Mason, Jill M., Hagen, Philip T., Rieck, Thomas M, Schroeder, Darrell

Mayo Clinic

American Journal of Health Promotion | March 21, 2018 | Volume: 32 | Issue: 8 | Pages: 1671-1678

10.1177/0890117118763273 | PMID 29558811 Get It

Purpose: Clinicians and fitness professionals are increasingly recommending the use of activity trackers. This study compares commercially available activity tracking devices for step and distance accuracy in common exercise settings. Design: Cross sectional. Setting: Rochester, Minnesota. Participants: Thirty-two men (n = 10) and women (n = 22) participated in the study. Measures: Researchers manually counted steps and measured distance for all trials, while participants wore 6 activity tracking devices that measured steps and distance. Analysis: We computed the difference between the number of steps measured by the device and the actual number of steps recorded by the observers, as well as the distance displayed by the device and the actual distance measured. Results: The analyses showed that both the device and walking trials affected the accuracy of the results (steps or distance, P < .001). Hip-based devices were more accurate and consistent for measuring step count. No significant differences were found among devices or locations for the distance measured. Conclusions: Hip-based activity tracking devices varied in accuracy but performed better than their wrist-based counterparts for step accuracy. Distance measurements for both types of devices were more consistent but lacked accuracy.
Gastrointestinal Symptoms in Diabetes: Prevalence, Assessment, Pathogenesis, and Management
Du, Yang , Rayner, Christopher K. , Jones, Karen L. , Horowitz, Michael , Du, Yang T , Talley, Nicholas J. , Rayner, C K , Jones, K L

Mayo Clinic

Diabetes Care | March 20, 2018 | Volume: 41 | Issue: 3 | Pages: 627-637

10.2337/dc17-1536 | PMID 29463666 Get It

If you haven’t measured something, you really don’t know much about it. —Karl Pearson (attributed)Gastrointestinal (GI) symptoms represent an important and often unappreciated cause of morbidity in diabetes, although the significance of this burden across the spectrum of patients and the underlying pathophysiology, including the relationship of symptoms with glycemic control, remain poorly defined. The relevance of GI symptoms and the necessity for their accurate assessment have increased with the greater focus on the gut as a therapeutic target for glucose lowering. This review addresses the prevalence, assessment, pathogenesis, and management of GI symptoms in diabetes, beginning with broad principles and then focusing on specific segments of the GI tract. We initially performed a literature search of PubMed by using synonyms and combinations of the following search terms: “gastrointestinal symptoms”, “diabetes”, “prevalence”, “pathogenesis”, “diagnosis”, and “management”. We restricted the search results to English only. Review papers and meta-analyses are presented as the highest level of evidence where possible followed by randomized controlled trials, uncontrolled trials, retrospective and observational data, and expert opinion.
Impact of Socioeconomic Status on Pretreatment Weight Loss and Survival in Non–Small-Cell Lung Cancer
Lau, Steven , Gannavarapu, Bhavani S., Carter, Kristen , Gao, Ang , Meyer, Jeffrey , Sher, David J. , Jatoi, Aminah , Infante, Rodney E. , Iyengar, Puneeth , Lau, Steven K M, Ahn, Chul, Meyer, Jeffrey J, Infante, Rodney, Ahn, Chul Woo

Mayo Clinic

Journal of Oncology Practice | March 20, 2018 | Volume: 14 | Issue: 4 | Pages: e211-e220

10.1200/jop.2017.025239 | PMID 29558251 Get It

Purpose: Socioeconomic status (SES) influences health care outcomes, but the influence of primary payer on cancer-associated wasting is unknown. We hypothesized that primary payer as an indicator of SES would influence pretreatment cancer-associated weight loss and treatment outcomes. Materials and Methods: Retrospective review of medical records identified 1,366 patients with non–small-cell lung cancer (NSCLC) consecutively treated at a tertiary care health system between January 1, 2006 and December 31, 2013. Insurance status was obtained from an institutional tumor registry. Cancer-associated weight loss was based on the validated international consensus definition of cachexia. Multivariable regression analyses were used to identify prognostic factors of pretreatment cancer-associated weight loss and survival. Results: The cohort included a representative group of patients with a median age at diagnosis of 64 years, 47% females, and 33% patients of nonwhite race. Pretreatment cancer-associated weight loss was present at the time of NSCLC diagnosis in 17%, 14%, 32%, and 38% of patients with stage I, II, III, and IV disease, respectively. Pretreatment cancer-associated weight loss was associated with increasing age at diagnosis, black race, single marital status, tobacco use, and disease stage. Compared with private insurance, Medicaid insurance (odds ratio, 2.17; 95% CI, 1.42 to 3.30) and lack of insurance (odds ratio, 2.32; 95% CI, 1.50 to 3.58) were associated with pretreatment cancer-associated weight loss. Among cachectic patients, comorbidity, histology, tumor grade, and disease stage were prognostic of survival on multivariable analysis; however, primary payer was not. Conclusion: Pretreatment cancer-associated weight loss is common in patients with NSCLC, and its presence is significantly associated with lower SES. However, among patients with pretreatment cancer-associated weight loss, SES was not predictive of survival. Early use of cancer cachexia–directed therapies may improve outcomes, and further study on the biologic mechanisms of cancer cachexia will provide novel therapeutic avenues.
Ibrutinib for the Management of Schnitzler Syndrome: A Novel Therapy for a Rare Condition
Jani, Prachi, Vissing, Megan Brinkworth, Ahmed, Salman , Sluzevich, Jason C. , Aulakh, Sonikpreet , Alegria, Victoria R., Ailawadhi, Meghna, Chanan‐Khan, Asher , Vissing, Megan B, Alegria, Victoria, Sluzevich, Jason C , Ailawadhi, Sikander

Mayo Clinic

Journal of Oncology Practice | March 20, 2018 | Volume: 14 | Issue: 6 | Pages: 387-388

10.1200/jop.18.00050 | PMID 29558252 Get It

Stem Cell Transplantation for Light Chain Amyloidosis: Decreased Early Mortality Over Time
Sidiqi, M Hasib , Aljama, Mohammed A. , Warsame, Rahma , Lacy, Martha Q. , Dingli, David , Kumar, Shaji , Kapoor, Prashant , Kourelis, Taxiarchis , Buadi, Francis K. , Warsame, Rahma M, Sidiqi, M Hasib , Dingli, David , Dispenzieri, Angela , Gonsalves, Wilson I. , Hogan, William J. , Gertz, Morie A.

Mayo Clinic

Journal of Clinical Oncology | March 20, 2018 | Volume: 36 | Issue: 13 | Pages: 1323-1329

10.1200/jco.2017.76.9554 | PMID 29558277 Get It

Purpose Autologous stem-cell transplantation (ASCT) has been used in patients with immunoglobulin light chain (AL) amyloidosis for more than two decades. Early experience raised concerns regarding safety with high early-mortality rates. Patients and Methods We report 20 years of experience with ASCT for AL amyloidosis at the Mayo Clinic Rochester. In all, 672 consecutive patients receiving ASCT for AL amyloidosis were divided into three cohorts on the basis of date of transplantation (cohort 1, 1996-2002 [n = 124]; cohort 2, 2003-2009 [n = 302]; and cohort 3, 2010-2016 [n = 246]). Results The median age for the entire cohort was 59 years, with patients in cohort 3 being slightly older than those in the other two cohorts (60 v 58 v 54 years for cohorts 3, 2, and 1, respectively; P < .001). Fewer patients in cohort 3 had more than two organs involved (9% v 18% v 19% for cohorts 3, 2, and 1, respectively; P < .001). More patients received pretransplantation therapy in cohort 3 compared with earlier time periods (49% v 38% v 42% for cohorts 3, 2, and 1, respectively; P = .02). Hematologic response was higher in cohort 3 (84% v 79% v 69% for cohorts 3, 2, and 1, respectively; P = .002). Median overall survival for the entire cohort was 122 months and improved over time (not reached v 120 months v 75 months for cohorts 3, 2, and 1, respectively; P < .001). Treatment-related mortality declined over time (2.4% v 8.6% v 14.5% for cohorts 3, 2, and 1, respectively; P < .001). On multivariable analysis, conditioning dose, Mayo stage 2012, and hematologic response were independent predictors of survival. Conclusion ASCT is a highly effective therapy for AL amyloidosis. The improved survival and markedly reduced treatment-related mortality in eligible patients indicate that this will remain an important first-line option even in the era of treatment approaches that use novel agents.
Microtubule associated tumor suppressor 1 interacts with mitofusins to regulate mitochondrial morphology in endothelial cells
Wang, Yinfang, Liu, Youbin , Li, Jin‐Ping , Hao, Yilong, Yin, Peihao , Liu, Zongjun , Chen, Jingzhou , Wang, Ying , Wang, Nanping , Zhang, Peng , Wang, Yinfang, Huang, Yitong Pepper , Wang, Ying

Mayo Clinic

The FASEB Journal | March 20, 2018 | Volume: 32 | Issue: 8 | Pages: 4504-4518

10.1096/fj.201701143rr | PMID 29558204 Get It

Mitochondria are dynamic organelles that are able to change their morphology and cellular distribution by either fission or fusion. However, the molecular mechanisms controlling mitochondrial dynamics in vascular endothelial cells (ECs) remain largely unknown. In this study, we observed that knockdown of microtubule‐associated tumor suppressor 1 (MTUS1) in ECs inhibited tube formation and migration, accompanied with decreased promigratory signalings. We showed that MTUS1 was localized in the outer membrane of mitochondria in ECs. Knockdown of MTUS1 disturbed the elongated mitochondrial network and induced the formation of perinuclear clusters of mitochondria. Importantly, mitochondrial motility and fusion were suppressed, whereas generation of reactive oxygen species was increased in MTUS1 knockdown ECs. Mechanistically, we showed that the N‐terminal coiled‐coil domain of MTUS1 interacted with the mitochondrial membrane proteins, mitofusin‐1 and mitofusin‐2, to maintain mitochondrial morphology in ECs. This study illustrated a novel role of MTUS1 in mitochondrial morphology and EC angiogenic responses.—Wang Y., Huang Y., Liu, Y., Li, J., Hao, Y., Yin, P., Liu, Z., Chen J., Wang Y., Wang N., Zhang P., Microtubule associated tumor suppressor 1 interacts with mitofusins to regulate mitochondrial morphology in endothelial cells. FASEB J . 32, 4504–4518 (2018). www.fasebj.org
Germline Lysine-Specific Demethylase 1 ( LSD1/KDM1A ) Mutations Confer Susceptibility to Multiple Myeloma
Wei, Xiaomu , Calvo-Vidal, M. Nieves, Chen, Siwei , Wu, Gang , Revuelta, María V. , Zhang, Jinghui , Walsh, Michael F. , Nichols, Kim E. , Vijai, Joseph , Snyder, Carrie, Vachon, Celine M. , McKay, James , Wang, Shuping , Jayabalan, David , Jacobs, Lauren , Becirovic, Dina, Waller, Rosalie G., Artomov, Mykyta , Viale, Agnès , Patel, Jayeshkumar , Curtin, Karen , Salama, Mohamed E. , Atanackovic, Djordje , Niesvizky, Rubén, Godley, Lucy A. , Churpek, Jane E. , Dumontet, Charles , Lynch, Henry T., Camp, Nicola J. , Offit, Kenneth , Klein, Robert J. , Lipkin, Steven M. , Waller, Rosalie G. , Griffin, R. L. , Joseph, Vijai , Revuelta, Maria , Waller, Rosalie G , Godley, Lucy A , Sun, Jian Hua , Vachon, Celine M. , Waller, Rosalie G., Phillip, Jude M. , Chen‐Kiang, Selina , Landgren, Ola , Slager, Susan L. , Garber, Judy E. , Anderson, Kenneth C. , Daly, Mark J. , Roeder, Robert G. , Mullighan, Charles G. , Yu, Haiyuan , Cerchietti, Leandro C. A. , Wu, Gang , Nichols, Kim E , Griffin, Rosalie , Klein, Robert , Churpek, Jane E , Churpek, Jane

Mayo Clinic

Cancer Research | March 20, 2018 | Volume: 78 | Issue: 10 | Pages: 2747-2759

10.1158/0008-5472.can-17-1900 | PMID 29559475 Get It

Abstract Given the frequent and largely incurable occurrence of multiple myeloma, identification of germline genetic mutations that predispose cells to multiple myeloma may provide insight into disease etiology and the developmental mechanisms of its cell of origin, the plasma cell (PC). Here, we identified familial and early-onset multiple myeloma kindreds with truncating mutations in lysine-specific demethylase 1 (LSD1/KDM1A), an epigenetic transcriptional repressor that primarily demethylates histone H3 on lysine 4 and regulates hematopoietic stem cell self-renewal. In addition, we found higher rates of germline truncating and predicted deleterious missense KDM1A mutations in patients with multiple myeloma unselected for family history compared with controls. Both monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma cells have significantly lower KDM1A transcript levels compared with normal PCs. Transcriptome analysis of multiple myeloma cells from KDM1A mutation carriers shows enrichment of pathways and MYC target genes previously associated with myeloma pathogenesis. In mice, antigen challenge followed by pharmacologic inhibition of KDM1A promoted PC expansion, enhanced secondary immune response, elicited appearance of serum paraprotein, and mediated upregulation of MYC transcriptional targets. These changes are consistent with the development of MGUS. Collectively, our findings show that KDM1A is the first autosomal-dominant multiple myeloma germline predisposition gene providing new insights into its mechanistic roles as a tumor suppressor during post-germinal center B-cell differentiation. Significance: KDM1A is the first germline autosomal dominant predisposition gene identified in multiple myeloma and provides new insights into multiple myeloma etiology and the mechanistic role of KDM1A as a tumor suppressor during post-germinal center B-cell differentiation. Cancer Res; 78(10); 2747–59. ©2018 AACR.